INTERNATIONAL PATENT: HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD., 杭州中美华东制药有限公司 FILES APPLICATION FOR "USE OF GLP-1 RECEPTOR AGONIST IN PREPARATION OF DRUG FOR TREATING OR PREVENTING PET DISEASES"

GENEVA, May 18 -- HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (No. 866, Moganshan Road, GongShu DistrictHangzhou, Zhejiang 310011), 杭州中美华东制药有限公司 (中国浙江省杭州市拱墅区莫干山路866号) filed a patent application (PCT/CN2025/132384) for "USE OF GLP-1 RECEPTOR AGONIST IN PREPARATION OF DRUG FOR TREATING OR PREVENTING PET DISEASES" on Nov 04, 2025. With publication no. WO/2026/098439, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) syste...